The Credit Suisse Liquid Alternative Beta (LAB) Index was flat in May, according to Dr Jordan Drachman, head of alternative beta strategies at Credit Suisse.
The merger arbitrage strategy was the strongest performer for the month, finishing up 1.25 per cent in May.
Two of the six strategies finished the month in negative territory – managed futures and global strategies – down 0.43 per cent and 0.21 per cent respectively.
